covid moderna - Search News

Order byBest matchMost fresh

Moderna, COVID and FDA

Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine

The submission is based on guidance from the U.S. FDA, which advised that COVID-19 vaccines should be updated to a monovalent JN.1 lineage, with a preference for the LP.8.1 variant.

· 9h · on MSN

Moderna files application for updated COVID vaccine

· 1d

FDA Warns of Heart Risk With Pfizer, Moderna COVID Vaccines

MIT Technology Review · 21h

The FDA plans to limit access to covid vaccines. Here’s why that’s not all bad.

Covid vaccines will soon be required to go through more rigorous trials to ensure that they really are beneficial for people who aren’t at high risk.

· 1d

FDA panel recommends keeping COVID shots targeted to same strain as last year

Alaska Dispatch News · 20h

Opinion: The FDA’s new covid vaccine policy is clear as mud

· 1d

US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026

Public health experts say that there is no certainty on which strains are going to be dominant.

· 15h

COVID shots should target newer strains of JN.1 variant, US FDA advisers say

· 1d

With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations

Moderna Pulls Promising Covid-Flu Combo Shot as RFK Continues Antivax Campaign

Moderna isn’t giving up on the combo shot entirely—it plans to resubmit later this year after it collects more data from its Phase III trials, which test how well a new treatment works compared to existing options.

1don MSN

U.S. reports cases of new COVID variant NB.1.8.1 behind surge in China

Preliminary data from researchers in China suggest the NB.1.8.1 variant is not better at evading the immune system compared to other strains on the rise, but it does have a greater ability to bind to human cells, suggesting it could be more transmissible.

3don MSN

FDA Will Limit Approvals for Covid-19 Shots. Moderna Stock Soars.

The question weighing on Moderna and other Covid-19 vaccine stocks in recent weeks has been whether the FDA will require drugmakers to run a new randomized, controlled trial befor

AARP4d

Third COVID Vaccine Gets Approved for Adults 65 and Over

Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) has officially approved a COVID-19 vaccine from Novavax for adults 65 and older and for individuals ages 12 to 64 who have an underlying health condition that puts them at higher risk for serious illness from a coronavirus infection.